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A best evidence topic in surgery was written according to a structured protocol. The question addressed
was whether prophylactic thoracic duct ligation during oesophagectomy results in a lower incidence of
post-operative chylothorax. 29 relevant papers were found using the reported search, of which 5 papers
represented the best evidence to answer the clinical question. The authors, date and country of publi-
cation, patient group, study type, relevant outcomes and results of these papers are tabulated. Of these
studies, only one was a prospective randomised controlled study with sizeable patient numbers. This was
also the most recent study and demonstrated a signiﬁcant decrease in post-operative chylothorax
incidence following intra-operative thoracic duct ligation. Of the four remaining retrospective studies,
one showed an increase in chylothorax rate following ligation whilst three showed a reduction in the
incidence of chylothorax (although in only one of these three studies was this decrease statistically
signiﬁcantly). We conclude that for patients undergoing oesophagectomy, although there are conﬂicting
results from retrospective studies, prospective randomised controlled trial evidence points to prophy-
lactic ligation of the thoracic duct as an effective measure to reduce the incidence of post-operative
chylothorax.
 2012 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
A best evidence article was constructed according to a struc-
tured protocol as described in a previous publication the Interna-
tional Journal of Surgery.1
2. Clinical scenario
You are performing an Ivor-Lewis oesophagectomy for a gastro-
oesophageal junctional oesophageal cancer. You have completed
the abdominal portion of the procedure and are about to perform
a right thoracotomy to mobilise the oesophagus. Your assistant
asks if you plan to ligate the thoracic duct as he has heard it
reduces the incidence of post-operative chylothorax. Although this
is not part of your routine practice, you resolve to check the
literature..
ciates Ltd. Published by Elsevier Lt3. Three-part question
In [patients who undergo an oesophagectomy], does [intra-
operative ligation of the thoracic duct] reduce the incidence of
[post-operative chylothorax]?
4. Search strategy
Medline 1966 to June 2011 using OVID interface for the terms
[Oesophagectomy.mp OR esophagectomy.mp] AND [chylothor-
ax.mp] AND [thoracic duct ligation.mp]. In addition, the reference
lists of the relevant papers were also searched.
5. Search outcome
29 papers were found using the reported search. Abstracts
were searched and only those papers which directly compared
the incidence of chylothorax in patients who underwent
prophylactic ligation with those who had conservative treatment
were selected. This yielded ﬁve papers (3 of which were ind. All rights reserved.
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fore chosen as representing the best relevant evidence to answer
this clinical question.
6. Results
The results of the ﬁve papers are summarised in Table 1.
7. Discussion
Post-operative chylothorax is a rare but potentially dangerous
complication of oesophagectomy, as it results in malnutrition and
immunosuppression and is associated with a high mortality rate.2
In the past decade, there has been some suggestion that routine
identiﬁcation and ligation of the thoracic duct may be of beneﬁt
during transthoracic oesophagectomy in reducing incidence of
post-operative chylothorax formation. Dougenis et al.3 performed
a retrospective analysis of 255 patients which compared elective
thoracic duct ligation (n ¼ 189) against patients who had their
thoracic ducts preserved (n ¼ 66). This study demonstrated
a statistically signiﬁcant reduction in chylothorax rates in patients
who had ligation. Similarly, Cagol et al.4 also showed a reduction in
incidence of chylothorax rates in the ligation group, however, their
overall incidence of post-operative chylothorax was very low and
no statistical analysis was performed. Lu et al.5 also foundTable 1
Best evidence papers.
Author, date
and country
Patient group Study type, level
of evidence
Out
Dougenis et al.,
1992 Scotland,
UK
255 patients underwent
transthoracic oesophagectomy
189 had elective intra-operative
ligation of thoracic duct
Single centre retrospective
study Level III
Chy
pres
Ove
com
Ove
mor
Fu et al., 2006
China
389 patients who underwent
transthoracic oesophagectomy
171 patients received thoracic
duct ligation, and 218 had
thoracic duct preserved
Single centre retrospective
cohort study Level III
Chy
pres
Ove
com
Ove
mor
5-ye
Lu et al., 2008
China
243 patients underwent
transthoracic oesophagectomy
Divided by tumour localization,
then subdivided into ligation
(117 patients) and preservation
groups (126 patients).
Single centre retrospective
study Level III
Chy
grou
Ove
com
Ove
mor
Cagol et al., 2009
Italy
1775 patients who had
undergone transthoracic
oesophagectomy 1452
were performed without
thoracic duct ligation
(1980e2000), and 323
had intra-operative thoracic
duct ligation (2001e2006)
Single centre retrospective
and prospective cohort
study Level III
Chy
grou
Ove
com
Ove
mor
Lai et al., 2011
China
653 patients who underwent
transthoracic oesophagectomy
were divided into 2 groups e
325 patients had thoracic
duct ligation during surgery;
328 patients were in the
preservation group
Single centre prospective
RCT Level II
Chy
grou
Ove
Ove
Bold signiﬁes p values of less than 0.05.a reduction in chylothorax rates in their study of 243 patients, but
this was not statistically signiﬁcant. In complete contrast, Fu et al.6
undertook a study of 389 patients which showed a statistically
signiﬁcant increase in post-operative chylothorax following liga-
tion. Interestingly, all of the papers showed that the development of
chylothorax led to adverse clinical consequences resulting in
a mortality rate of around 20%.3e7 This therefore implies that
reduction of chylothorax rates is an important clinical goal.
It should be noted that prior to 2011, all studies on this topic
were retrospective in nature.3e6 The only large-scale prospective
study on this subject was recently published by Lai et al,7 who
conducted a trial of 653 transthoracic oesophagectomy patients
and randomised them to a ligation group and a preservation group.
The demographic details in both groups were similar however they
noted a statistically signiﬁcant reduction in chylothorax rates in the
ligation group. In particular, the ligation group had only 1 patient
with a chylothorax (which resulted in no adverse clinical sequelae)
whilst 7 patients in the preservation group had chylothoraces (of
whom 4 had signiﬁcant clinical complications secondary to the
chylothorax resulting in 2 deaths).
With respect to the potential complications associated with the
process of ligation itself, the only comprehensive study on this
subject was conducted by Fu et al.4 This study, which unlike all
previous studies showed an increase in chylothorax rates after liga-
tion, also analysed the impact of ligation itself on post-operativecomes Key results Comments
lothorax rate (ligation vs.
ervation group)
2.1% vs 9%
(p < 0.05)
This initial study showed a
signiﬁcant decrease in
incidence of chylothorax
in ligation group. It should
be noted that the overall
mortality rate in the ligation
group was high 10%.
rall post-operative
plication rate
Not stated
rall post-operative
tality rate
Not stated
lothorax rate (ligation vs.
ervation group)
1.17% vs 0.46%
(p < 0.001)
This study showed signiﬁcant
increase in the incidence of
chylothorax rate following
prophylactic thoracic duct
ligation. Complication rate
in ligation group were also
higher, but not statistically
signiﬁcant and the long-term
survival rates were comparable.
rall post-operative
plication rate
18.2% vs 11.5%
(p ¼ 0.063)
rall post-operative
tality rate
1.75% vs 0.92%
(p ¼ 0.658)
ar survival rates 29.2% vs 29.8%
(p ¼ 0.902)
lothorax rate (ligation
p vs. preservation group)
2.1% vs 3.7%
(p > 0.05)
This study found no signiﬁcant
difference in chylothorax rates
between ligation and non-ligation
subgroups. It should be noted
that the overall mortality of the
cohort is very low at 0.82%.
rall post-operative
plication rate
Not stated
rall post-operative
tality rate
Not stated
lothorax rate (ligation
p vs. preservation group)
0% vs 0.9% This study advocates intra-operative
mass thoracic duct ligation as a safe
and preventative method for
chylothorax prevention. However,
the study did not statistically
analyse chylothorax rates of both
groups, and did not state the
overall complication and mortality
rates of the two groups.
rall post-operative
plication rate
Not stated
rall post-operative
tality rate
Not stated
lothorax rate (ligation
p vs. preservation group)
0.3% vs 2.1%
(p [ 0.046)
This study supported the notion
of thoracic duct ligation. 1 patient
in the ligation group had a
chylothorax with no clinical
signiﬁcance. 7 patients in
preservation group had
chylothoraces resulting in
4 complications (chest infection,
ARDS, MOF in 2) which in turn
led to 2 deaths)
rall complication rate Not stated
rall mortality rate Not stated
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mortality rate and complication rate in the ligation group, but this
was not statistically signiﬁcant. Interestingly, they noted no advan-
tage or detriment in long-term survival rates of patients who
underwent ligation. It should be noted that Cagol et al.5 and Lai et al.7
stated their cohorts had no complications or deaths related to the
process of ligation. However, they do not state the comparative
morbidity or mortality rates of the two groups; hence their conclu-
sionscannotbevalidated.Moreoveronreviewing theevidence, there
does not appear to be standard technique for thoracic duct ligation.
For example, Cagol et al.5 described mass ligation using absorbable
polyglactin,whilst Lai et al.7 alsoperformedmass ligationusing three
non-absorbable sutures. In addition, there is to date no data on the
efﬁcacy of mass ligation versus formal identiﬁcation and ligation (or
indeed excision of a segment) of the thoracic duct. Finally there have
been no studies comparing suture ligation with mechanical ligation
or ligation using energy devices.
There are a number of limitations in all of these studies which
require discussion. For a start, there is some evidence to suggest
that the site of the tumour has an impact on the incidence of
chylothorax,6 and this may be a statistical confounder in analysing
the results of all of these studies. Similarly, Bolgar et al.8 have
suggested that histological type of the tumour and lymph node
involvement may affect chylothorax rates, and these factors are
further potential statistical confounders. In addition, there is some
heterogeneity in the pre-operative management of the patients in
these studies. For instance, in the study by Cagol et al.,5 half the
patients received pre-operative chemoradiotherapy. More funda-
mentally, none of the papers had a standardized deﬁnition of what
volume of chest drain output constitutes a post-operative chylo-
thorax. Finally, with the exception of the paper by Fu et al.,4 there is
no data on the overall complication, mortality, survival rate and the
potential long-term oncological impact of ligating the thoracic duct.
In summary, on reviewing the data, as the only prospective
randomised controlled study with sizeable patient numbers
demonstrated a signiﬁcant decrease in post-operative chylothorax
rates following intra-operative thoracic duct ligation, we concur
with their conclusion that patients undergoing oesophagectomy
should have prophylactic thoracic duct ligation. However, the
impact of thoracic duct ligation on overall post-operative compli-
cations as well as long-term oncological outcomes have yet to be
deﬁnitively assessed and proven.
8. Clinical bottom line
For patients undergoing oesophagectomy, although there
are conﬂicting results from retrospective studies, prospectiverandomised controlled trial evidence points to prophylactic ligation
of the thoracic duct as an effective measure to reduce the incidence
of post-operative chylothorax.Conﬂict of interest
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